Craniosynostosis autosomal dominant
Craniosynostosis, Autosomal Dominant is a genetic condition characterized by the premature fusion of certain skull bones. This early fusion prevents the skull from growing normally and affects the shape of the head and face. Craniosynostosis can lead to increased intracranial pressure, developmental delays, and facial deformities if not treated. The autosomal dominant form of craniosynostosis indicates that the condition can be inherited from just one affected parent due to a mutation in a gene that follows an autosomal dominant pattern of inheritance.
Causes[edit | edit source]
The condition is caused by mutations in specific genes that are involved in the development and growth of skull bones. These genes include, but are not limited to, FGFR2, TWIST1, and MSX2. Mutations in these genes disrupt the normal balance between bone formation and resorption, leading to the premature fusion of skull sutures.
Symptoms[edit | edit source]
Symptoms of autosomal dominant craniosynostosis may vary depending on which sutures fuse early. Common symptoms include an abnormally shaped head, a misshapen face, and possibly a protruding forehead. In severe cases, the condition can lead to visual impairments, sleep apnea, and difficulties with eating and breathing.
Diagnosis[edit | edit source]
Diagnosis of craniosynostosis typically involves a physical examination, imaging studies such as X-rays or CT scans to view the sutures of the skull, and genetic testing to identify any mutations associated with the condition.
Treatment[edit | edit source]
Treatment often involves surgery to correct the shape of the skull and allow for normal brain growth. Surgical procedures may vary depending on the sutures involved and the age of the patient. In some cases, a helmet may be used after surgery to help shape the skull as it heals.
Prognosis[edit | edit source]
The prognosis for individuals with autosomal dominant craniosynostosis varies. Early diagnosis and treatment can lead to improved outcomes, including normal brain development and a reduction in the risk of complications. However, some individuals may experience lasting effects, such as cognitive challenges or physical limitations.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD